Kenvue

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Kenvue (KVUE) reports strong Q2 earnings, eyes China growth

Kenvue's Q2 performance showcased robust net sales, organic growth, and strategic investments in key segments. The company's focus on consumer trust, supply chain enhancements, and capital allocation strategy underpin its resilience. Challenges include managing inflationary pressures and sustaining growth post-COVID, but opportunities in China and ongoing investments position Kenvue for future success.

Kenvue (KVUE) reports solid Q3 performance amidst segment challenges

Kenvue (KVUE) delivered a solid Q3 performance, showcasing strength in key segments despite challenges in others.
The company's strategic initiatives, focus on innovation, and outlook for growth opportunities position it well for future success.
Efforts to address challenges in specific segments and capitalize on opportunities demonstrate a proactive approach to sustaining growth and profitability.
Overall positive outlook on third-quarter results reflects the company's strong model, portfolio, and cash flow generation capabilities.

Kenvue reports mixed 2023 performance, focuses on growth strategies

Kenvue's 2023 performance saw organic growth but faced challenges in specific segments, leading to adjustments for 2024. The company aims to drive growth through operational efficiencies, increased brand investments, and a focus on consumer engagement. Challenges in U.S. in-store execution prompted a recovery plan and leadership changes.

Kenvue surpasses Q1 expectations, eyes China growth amid challenges

Kenvue's Q1 performance exceeded expectations, driven by key segments and brands.
Strategic focus on cost optimization, operational efficiency, and brand impact.
Challenges include stabilizing declining segments and managing hyperinflation impact.
Opportunities lie in growing China business, operational reinvention, and new leadership.

Kenvue reports solid Q2 performance and optimistic outlook for 2024

Kenvue's Q2 performance reflects steady growth and improved profitability, driven by strategic initiatives and strong brand performance. While cost management and increased marketing spend pose challenges, the company's focus on brand investment and long-term value creation offers promising opportunities for future growth and shareholder returns.

Kenvue reports Q3 growth, tackles Skin Health challenges, eyes savings

Kenvue's Q3 performance showed organic growth and strong financial metrics.
While facing challenges in the Skin Health segment, the company is focusing on recovery.
Investments in marketing and efficiency improvements highlight growth opportunities.
Executives addressed key questions on guidance, inventory levels, and growth strategies.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Kenvue, Inc. is a consumer health company. It operates through the following business segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care and hair, sun and others. The Essential Health segment focuses on oral care, baby care, women's health and wound care. The company was founded on February 23, 2022 and is headquartered in Skillman, NJ.

If you suffered losses exceeding $100,000 investing in Kenvue securities pursuant and/or traceable to the registration statement and related prospectus (collectively, the "Registration Statement") issued in connection with the Company's May 2023 initial public offering (the "IPO" or "Offering") and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330  (Ext. 1310). You may also click here for additional information: http://www.faruqilaw.com/KVUE.

KENVUE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Kenvue To Contact Him Directly To Discuss Their Options

NEW YORK , Dec. 5, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Kenvue Inc. ("Kenvue" or the "Company") (NYSE: KVUE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Kenvue investors who were adversely affected by alleged securities fraud.

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Kenvue Inc.(KVUE) Investors of a Class Action Lawsuit and Upcoming Deadline

LOS ANGELES, CA / ACCESSWIRE / December 5, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Kenvue Inc. ("Kenvue" or "the Company") (NYSE:KVUE) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's May 2023 initial public offering ("IPO"), are encouraged to contact the firm before December 8, 2023.

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Kenvue Inc. with Losses of $100,000 to Contact the Firm

Vici Properties

November was the best month for the S&P 500 since July 2022, breaking a three-month losing streak. The stock market appears overvalued after the strong November performance, suggesting a minor pullback may be needed. 3 undervalued dividend stocks to consider buying in December are Kenvue, 3M, and VICI Properties.

3 Dividend Stocks Worthy Of A Buy In December 2023

NEW YORK , Dec. 4, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Kenvue Inc.. Shareholders who purchased shares of KVUE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Kenvue Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 8, 2023 - (NYSE: KVUE)

CVS Health

Patterson Companies

Premier

Select Medical Holdings

Spok Holdings

U.S. Physical Therapy

With concerns about a slowdown in the global economy rising, investors may be better served considering the top healthcare hidden-gem stocks. To be sure, no guarantees exist in the market; otherwise, everyone would pour money into the guaranteed space.

Wealth From Wellness: 7 Healthcare Stocks to Inoculate Your Portfolio

LOS ANGELES, CA / ACCESSWIRE / November 30, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Kenvue Inc. ("Kenvue" or "the Company") (NYSE:KVUE) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's May 2023 initial public offering ("IPO"), are encouraged to contact the firm before December 8, 2023.

FINAL DEADLINE DECEMBER 8: The Schall Law Firm Encourages Investors in Kenvue Inc. with Losses of $100,000 to Contact the Firm

Cava Group, Inc.

Savers Value Village Inc

The initial public offering (IPO) market has not done well in 2023. The most recent deals have faltered, falling below their IPO pricing on day one or soon after.

Fresh on the Market: 3 Top Picks From the Renaissance IPO ETF

If you purchased or acquired securities in Kenvue securities pursuant and/or traceable to the registration statement and related prospectus (collectively, the "Registration Statement") issued in connection with the Company's May 2023 initial public offering (the "IPO" or "Offering") and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330  (Ext. 1310). You may also click here for additional information: http://www.faruqilaw.com/KVUE.

KENVUE INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Kenvue To Contact Him Directly To Discuss Their Options

DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Kenvue Inc. with Losses of $100,000 to Contact the Firm

NEW YORK , Nov. 29, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Kenvue Inc. (NYSE: KVUE) pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with the Company's May 2023 initial public offering ("IPO" or the "Offering"), of the important December 8, 2023 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Kenvue securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

KVUE DEADLINE: NATIONALLY RANKED ROSEN LAW FIRM Encourages Kenvue Inc. Investors to Secure Counsel Before Important December 8 Deadline in Securities Class Action First Filed by the Firm - KVUE

ARM Holdings PLC

Birkenstock Holding Plc

Golden Heaven Group Holdings Ltd

Johnson & Johnson

NEXTracker Inc

Rivian Automotive

So far in 2023, 146 companies have gone public in the U.S. markets, down 16.09% from the same time last year. Although the IPO market has been choppy amid higher interest rates and broad equity market uncertainty, the new companies as a whole have outperformed the S&P 500.

2023's most anticipated IPOs weren't always the big winners

NEW YORK , Nov. 28, 2023 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Kenvue, Inc. ("Kenvue" or the "Company") (NYSE: KVUE) and certain officers.   The class action, filed in the United States District Court for the District of New Jersey, and docketed under 23-cv-22435, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Kenvue securities pursuant and/or traceable to the registration statement and related prospectus (collectively, the "Registration Statement") issued in connection with Kenvue's initial public offering (the "IPO" or "Offering") and suffered compensable damages caused by Defendants' violations of the Securities Act of 1933 (the "Securities Act").

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Kenvue, Inc. of Class Action Lawsuit and Upcoming Deadline - KVUE

SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE), today announced the company's participation in Morgan Stanley's Global Consumer & Retail Conference, in New York.

Kenvue to Participate in the Morgan Stanley Global Consumer & Retail Conference on December 6, 2023

NEW YORK , Nov. 27, 2023 /PRNewswire/ -- Attention Kenvue Inc. ("Kenvue") (NYSE: KVUE) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors. This lawsuit is on behalf of persons who purchased or otherwise acquired Kenvue securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with Kenvue's May 2023 initial public offering.

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Kenvue Investors of a Lead Plaintiff Deadline of December 8, 2023

Dividend stocks became unattractive due to weak equities and high Treasury rates, but some are starting to look more attractive again. Kenvue, a spin-off from Johnson & Johnson, lacks growth potential and has stagnant margins and revenue growth. Kenvue's high debt and limited free cash flow make it unlikely to sustain dividend growth, and its valuation is unattractive compared to J&J.

Kenvue: Dude, Where's My Dividend Growth?

RADNOR, Pa. , Nov. 25, 2023 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Kenvue Inc. ("Kenvue") (NYSE: KVUE).

KVUE SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Kenvue Inc. (KVUE)

RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against Kenvue Inc. (“Kenvue”) (NYSE: KVUE). The action charges Kenvue with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of Kenvue's.

Important December 8, 2023 Deadline Reminder for Kenvue Inc. Investors: Kessler Topaz Meltzer & Check, LLP Reminds Kenvue Inc. (KVUE) Investors of Securities Fraud Class Action Lawsuit

NEW YORK , Nov. 21, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Kenvue Inc. (NYSE: KVUE) pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with the Company's May 2023 initial public offering ("IPO" or the "Offering"), of the important December 8, 2023 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Kenvue securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, THE FIRST FILING FIRM, Encourages Kenvue Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - KVUE

Apple

Amazon

Microsoft

Hedge funds are managed by professional fund managers and consist of pooled investment funds from various investors. Hedge funds must file a 13-F with the SEC, which shows their buys and sells for the quarter. Here are the top 5 most purchased individual stocks by hedge funds during the most recent quarter.

Top 5 Stocks The Smart Money Is Buying

LOS ANGELES, CA / ACCESSWIRE / November 21, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Kenvue Inc. ("Kenvue" or "the Company") (NYSE:KVUE) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's May 2023 initial public offering ("IPO"), are encouraged to contact the firm before December 8, 2023.

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Kenvue Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / November 19, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Kenvue Inc. ("Kenvue" or "the Company") (NYSE:KVUE) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's May 2023 initial public offering ("IPO"), are encouraged to contact the firm before December 8, 2023.

INVESTOR DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Kenvue Inc. with Losses of $100,000 to Contact the Firm

KENVUE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Kenvue To Contact Him Directly To Discuss Their Options

LOS ANGELES, CA / ACCESSWIRE / November 17, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Kenvue Inc. ("Kenvue" or "the Company") (NYSE:KVUE) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's May 2023 initial public offering ("IPO"), are encouraged to contact the firm before December 8, 2023.

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Encourages Investors in Kenvue Inc. with Losses of $100,000 to Contact the Firm

RADNOR, Pa. , Nov. 16, 2023 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Kenvue Inc. ("Kenvue") (NYSE: KVUE).

News for Kenvue Stock (KVUE)